The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Clinical and Molecular Hepatology. 2022;28(3):351-361 
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
Pathologie Biologie. 2010;58(4):273-277
Predictive Scores for Hepatocellular Carcinoma Development in Chronic Hepatitis B Virus Infection: “Does One Size Fit All?”
Gastroenterology. 2012;142(4):1038-1040
Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C
Hepatology. 2011;54(1):373-373
Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection
Viruses. 2022;14(9):1968
P550 RISK PREDICTION MODEL OF HEPATOCELLULAR CARCINOMA IN KOREAN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
Journal of Hepatology. 2014;60(1):S252
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis
Histopathology. 2001;39(1):66-73
Long-term monitoring, and hepatocellular carcinoma surveillance in patients with chronic hepatitis B infection
. 2022;
468 Occult hepatitis B virus infection is associated with carcinogenesis of hepatocellular carcinoma in patients with liver cirrhosis in chronic hepatitis C virus carriers
Journal of Hepatology. 2005;42:170
Thyroxine-binding globulin, hyperthyroxinemia and hepatocellular carcinoma Huang M-J, Liaw Y-F. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma. Am J Gastroentol 1990;85:281–284
Hepatology. 1991;13(4):808-809